ArticleMolecular cancer therapeutics2023

SGN-B6A: A New Vedotin Antibody-Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications.

Robert P Lyon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.